Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis

How often should we expect to be wrong? Statistical power, P values, and the expected prevalence of false discoveries

(2018) Michael J. Marino   BIOCHEMICAL PHARMACOLOGY

Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies

(2018) Carlijn R. Hooijmans et al.   PLoS One

Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial

(2017) Dennis Chan et al.   LANCET NEUROLOGY

Regenerating CNS myelin — from mechanisms to experimental medicines

(2017) Robin J. M. Franklin et al.   NATURE REVIEWS NEUROSCIENCE

Sudan black: a fast, easy and non-toxic method to assess myelin repair in demyelinating diseases

(2017) Benjamin V. Ineichen et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Valproic acid and ASK1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis

(2017) Yuriko Azuchi et al.   NEUROSCIENCE LETTERS

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

(2017) Xavier Montalban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Standardized mean differences cause funnel plot distortion in publication bias assessments

(2017) Peter-Paul Zwetsloot et al.   eLife

Multiple sclerosis: experimental models and reality

(2016) Hans Lassmann et al.   ACTA NEUROPATHOLOGICA

Reproducible Research Practices and Transparency across the Biomedical Literature

(2016) Shareen A. Iqbal et al.   PLOS BIOLOGY

A systematic review and meta-analysis of the ability of analgesic drugs to reduce metastasis in experimental cancer models

(2015) Carlijn R. Hooijmans et al.   PAIN

SYRCLE’s risk of bias tool for animal studies

(2014) Carlijn R Hooijmans et al.   BMC Medical Research Methodology

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

(2014) Jeremy Chataway et al.   LANCET

Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats

(2014) Gonçalo Castelo-Branco et al.   NEUROBIOLOGY OF DISEASE

The use of valproic acid and multiple sclerosis

(2014) Nete Munk Nielsen et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Role of statins in the treatment of multiple sclerosis

(2014) Rosella Ciurleo et al.   PHARMACOLOGICAL RESEARCH

SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis

(2013) N. M. Moll et al.   GLIA

Cuprizone-Induced Demyelination as a Tool to Study Remyelination and Axonal Protection

(2013) Adib Zendedel et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Power failure: why small sample size undermines the reliability of neuroscience

(2013) Katherine S. Button et al.   NATURE REVIEWS NEUROSCIENCE

Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study

(2012) Juan G Quispe-Cabanillas et al.   BMC Complementary and Alternative Medicine

Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus

(2012) Miriam Mecha et al.   PROGRESS IN NEUROBIOLOGY

Semi-quantitative analysis of the effects of cyclosporine on remyelination following gliotoxic injection in the brainstem

(2011) E F Bondan et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

(2011) Per Soelberg Sorensen et al.   LANCET NEUROLOGY

Improving the translational hit of experimental treatments in multiple sclerosis

(2010) Hanna M Vesterinen et al.   Multiple Sclerosis Journal

Myelination and support of axonal integrity by glia

(2010) Klaus-Armin Nave   NATURE

Gain-of-Function of Olig Transcription Factors Enhances Oligodendrogenesis and Myelination

(2010) Cécile L. Maire et al.   STEM CELLS

Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

(2010) Carol Kilkenny et al.   PLOS BIOLOGY

The cuprizone animal model: new insights into an old story

(2009) Markus Kipp et al.   ACTA NEUROPATHOLOGICA

Statin Therapy Inhibits Remyelination in the Central Nervous System

(2009) Veronique E. Miron et al.   AMERICAN JOURNAL OF PATHOLOGY

Lovastatin induces the formation of abnormal myelin-like membrane sheets in primary oligodendrocytes

(2008) Olaf Maier et al.   GLIA

Reprint: Good Laboratory Practice: Preventing Introduction of Bias at the Bench

(2008) Malcolm R Macleod et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency

(2008) Siming Shen et al.   NATURE NEUROSCIENCE